ArticleJournal of bone oncology2018

Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer.

Vanessa Rouach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.